Current screening methods miss worrisome number of persons

screening MIAMI: Mild cognitive impairment (MCI) is a slight but noticeable and measurable decline in cognitive abilities, such as remembering names or a list of items. While changes may not be severe enough to disrupt daily life, a clinical diagnosis of MCI indicates an increased risk of eventually developing Alzheimer’s disease or another type of dementia.

In a paper researchers say existing screening tools for MCI result in a false-negative error rate of more than 7 percent. These persons are misclassified as not having MCI based on standard screening instruments, but actually do have MCI when more extensive testing is conducted….

Full story covered in the Dementia Business Weekly.